Tenax Therapeutics (TENX) Interest Coverage Ratio (2010 - 2026)
Tenax Therapeutics (TENX) reported Interest Coverage Ratio of 0.24 for Q1 2026, up 100.0% on a YoY basis from 0.12 in Q1 2025, and up 84.48% sequentially from 1.53 in Q3 2025.
Tenax Therapeutics (TENX) Interest Coverage Ratio (2010 - 2026) Analysis & Trends
Tenax Therapeutics (TENX) has 15 years of Interest Coverage Ratio data on file, last reported at 0.24 in Q1 2026.
- For the quarter ending Q1 2026, Interest Coverage Ratio rose 100.0% year-over-year to 0.24; the trailing twelve-month figure through Mar 2026 stood at 0.88 (up 99.99% YoY), and the FY2025 full-year result was 1.12, down 139.4% from the prior year.
- Interest Coverage Ratio advanced to 0.24 in Q1 2026, from 1.53 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 7295.0 in Q4 2024 to a low of 5939.24 in Q1 2025.
- A 5-year average of 701.18 and a median of 1.53 in 2025 frame the typical range for Interest Coverage Ratio.
- Across the five-year window, Interest Coverage Ratio soared 926.43% in 2023 and sank 1345.49% in 2025, its largest moves.
- Tracing TENX's Interest Coverage Ratio over 5 years: stood at 12.82 in 2022, then plunged by 36036.29% to 4607.58 in 2023, then jumped by 258.33% to 7295.0 in 2024, then sank by 100.02% to 1.53 in 2025, then jumped by 84.48% to 0.24 in 2026.
- Business Quant data shows TENX's Interest Coverage Ratio at 0.24 in Q1 2026, 1.53 in Q3 2025, and 5896.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Tenax Therapeutics | 67,856.40 | 67,856.40 | - | -0.24 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.24 |
| Sep 30, 2025 | -1.53 |
| Jun 30, 2025 | -5,896.00 |
| Mar 31, 2025 | -5,939.24 |
| Dec 31, 2024 | 7,295.00 |
| Sep 30, 2024 | -659.86 |
| Jun 30, 2024 | -407.89 |
| Mar 31, 2024 | -488.63 |
| Dec 31, 2023 | -4,607.58 |
| Sep 30, 2023 | 131.60 |
| Jun 30, 2023 | 68.23 |
| Mar 31, 2023 | -44.78 |
| Sep 30, 2022 | 12.82 |
| Jun 30, 2022 | 11.02 |
| Mar 31, 2022 | 9.35 |
| Sep 30, 2021 | 10.76 |
| Jun 30, 2021 | 15.52 |
| Mar 31, 2021 | 762.33 |
| Dec 31, 2020 | 1,071.99 |
| Sep 30, 2020 | 24.13 |